XML 83 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 29, 2013
Mar. 30, 2012
Cash flows from operating activities:    
Net income (loss) $ 5,663 $ 4,467
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 8,764 11,119
Debt related amortization included in interest expense 5,759 2,956
Stock-based compensation 2,431 2,187
Other non-cash (gains) losses (930) 165
Deferred income taxes (29,212) 123
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (3,897) (13,605)
Inventories (12,073) (1,910)
Prepaid expenses and other current assets 80 848
Accounts payable (512) 4,958
Accrued expenses (13,920) (12,734)
Income taxes payable 30,252 1,016
Net cash provided by (used in) operating activities (7,595) (410)
Cash flows from investing activities:    
Acquisition of property, plant and equipment (6,745) (9,836)
Proceeds from sale of orthopaedic product lines 1,768 0
Net proceeds from sale (purchase) of cost and equity method investments, net (810) 0
Acquisitions, net of cash acquired 0 (17,224)
Other investing activities 8 38
Net cash provided by (used in) investing activities (5,779) (27,022)
Cash flows from financing activities:    
Principal payments of long-term debt (205,782) (10,000)
Proceeds from issuance of long-term debt 208,000 10,000
Issuance of common stock 1,185 223
Payment of debt issuance costs 0 0
Other financing activities (81) (118)
Net cash provided by (used in) financing activities 3,322 105
Effect of foreign currency exchange rates on cash and cash equivalents (88) 353
Net increase (decrease) in cash and cash equivalents (10,140) (26,974)
Cash and cash equivalents, beginning of period 20,284 36,508
Cash and cash equivalents, end of period $ 10,144 $ 9,534